AIC
TEVA icon

Ayalon Insurance Company’s Teva Pharmaceuticals TEVA Stock Holding History

Ayalon Insurance Company’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,267
Closed -$42K – 164
2021
Q2 		$42K Buy
4,267
+1,973
+86% +$20.9K 0.01% 155
2021
Q1 		$26K Buy
+2,294
New +$26.3K 0.01% 148

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ayalon Insurance Company's TEVA Position: Q3 2021 in Review

Ayalon Insurance Company sold out of Teva Pharmaceuticals (TEVA) in Q3 2021, closing a stake of 4,267 shares — an estimated $42K sold.

Ayalon Insurance Company first reported a position in TEVA in Q1 2021 and held it in 2 quarters. The position peaked at $42K in Q2 2021. 429 funds tracked by Wall St. Rank hold TEVA as of Q3 2021.

  • Ayalon Insurance Company reported no remaining Teva Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Ayalon Insurance Company sold 4,267 Teva Pharmaceuticals shares in Q3 2021, an estimated $42K.
  • Ayalon Insurance Company first reported a position in Teva Pharmaceuticals in Q1 2021 and held it in 2 quarters.
  • Ayalon Insurance Company's Teva Pharmaceuticals position peaked at $42K in Q2 2021.
  • 429 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2021.

Based on Ayalon Insurance Company's 13F filing for Q3 2021, filed 13 Oct 2021.